pharmaceutical
30 articole · RSS
Amgen vinde drepturile asupra unor medicamente catre Takeda Pharmaceutical, pentru 1,2 mld. dolari
Compania americana de biotehnologie Amgen vinde drepturile asupra unor medicamente catre Takeda Pharmaceutical, cel mai mare producator de medicamente din Japonia, pentru maxim 1,2 miliarde...
Pharmaceutical market to exceed 2bn euros in 2008
The Romanian pharmaceutical market is expected to grow by around 15% in 2008, to 2.2bn euros, in line with the estimates made by major players in the industry. As a result, drug sales will m...
Producers derive profits of almost 50m euros on the pharmaceutical market
The main drug manufacturers in Romania registered profits of approximately 50m euros last year, compared with over 35m euros posted in 2005, according to ZF data. As a result, the biggest do...
Actavis, first foreign greenfield pharmaceutical investor in Romania
Drug producer Actavis, one of the top ten players on the world market of generic drugs (equivalent to the patent drugs, produced after the licence of the patent drugs expires, and which have...
Domestic pharmaceutical market boasts fastest growth in CEE
The domestic pharmaceutical market is witnessing the fastest growth pace of all the Central and East-European states, being outrun only by Russia, believes A.T. Kearney consultancy. Pharmace...
Pharmaceutical consumption could match European level in 6 years
Pharmaceutical consumption per capita in Romania amounted to around 70 euros last year, up from 57 euros in 2005. By comparison, drug consumption in France stands at 400 euros per capita, an...
Technophar, $36m in pharmaceutical equipment
Technophar, $36m in pharmaceutical equipment
Pharmaceutical market heading for 2.5bn euros
The Romanian pharmaceutical market is likely to go beyond the 2.5bn-euro mark over the next five years, whereas competition between the main players will become tighter. "Over the next four-...
Ranbaxy closes biggest transaction on pharmaceutical market
Indian pharmaceutical company Ranbaxy acquired drugmaker Terapia Cluj-Napoca for 325 million dollars (approximately 270m euros). The seller is investment fund Advent International, which bou...